Tech Company Financing Transactions

Oncologie Funding Round

Oncologie closed a $80 million Series B funding round on 6/11/2019. Investors included Nan Fung Life Sciences, Pivotal bioVenture Partners and Korea Investment Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

400 Totten Pond Rd. 120
Waltham, MA 02451
USA

Phone

(781) 907-7810

Website

www.oncologie.international

Email Address

Not Recorded

Overview

We are developing innovative medicines for cancer patients around the world. Using cutting edge approaches to patient selection and clinical trial design, Oncologie is developing next-generation biologics and small molecules. Oncologie's portfolio covers the spectrum of the cancer immunology landscape.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Laura Benjamin

        

Chief Medical Officer

Hagop Youssoufian

        

VP - Bus. Development

David Malek

        

VP - Bus. Development

Jessicca Rege

        

Browse more venture capital transactions:

Prev: 6/11/2019: Alyce venture capital transaction
Next: 6/11/2019: Alkami Technology venture capital transaction

Share this article

About Database of VC Transactions

We record every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary